![Michael Gladstone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Gladstone
Directeur/Membre du Conseil chez
THIRD HARMONIC BIO, INC.
Profil
Michael Gladstone is the founder of Q32 Bio Operations, Inc. Current roles include Director at Kailera Therapeutics, Inc. since 2024; Director at DOT Therapeutics-2, Inc.; Independent Director at Third Harmonic Bio, Inc. since 2019; Non-Executive Director & Board Member at Versanis Bio, Inc.; Director at Diagonal Therapeutics, Inc.; Director at Aiolos Bio, Inc.; Partner at Atlas Venture Advisors, Inc. since 2020; Principal at Padlock Therapeutics, Inc.; Partner at Atlas Venture Life Science Advisors LLC since 2020; and Board Member at Pheon Therapeutics Ltd. since 2022.
Former roles include Independent Director at Day One Biopharmaceuticals, Inc.; Operations Director at Spero Therapeutics, Inc.; Director-Business Operations at Surface Oncology, Inc.; Director at Replimune Group, Inc.; Director at AVROBIO, Inc.; Director at IFM Therapeutics LLC; Director at Delinia, Inc.; Director at Indalo Therapeutics, Inc.; Director at Akero Therapeutics, Inc.; Director at Xilio Therapeutics LLC; Senior Associate Consultant at The Lek; and Principal at Beth Israel Deaconess Medical Center, Inc. Education includes an undergraduate degree from Harvard College, conferred in 2009.
Postes actifs de Michael Gladstone
| Sociétés | Poste | Début |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Directeur/Membre du Conseil | 01/04/2019 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/05/2015 |
Diagonal Therapeutics, Inc.
 Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for oncology, immunology and rare diseases | Directeur/Membre du Conseil | - |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Private Equity Investor | 01/05/2015 |
Pheon Therapeutics Ltd.
 Pheon Therapeutics Ltd. BiotechnologyHealth Technology Develops antibody drug to treat cancers | Directeur/Membre du Conseil | 14/03/2022 |
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Directeur/Membre du Conseil | - |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Corporate Officer/Principal | - |
Anciens postes connus de Michael Gladstone
| Sociétés | Poste | Fin |
|---|---|---|
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Analyste en capital-investissement | 31/12/2011 |
| ░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | - |
| ░░░ ░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Michael Gladstone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
The Lek/Alcar Consulting Group, Inc.
The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Padlock Therapeutics, Inc.
Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for seed and early stage capital requirements. | Finance |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
IFM Therapeutics LLC
 IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology Discovers and develops small molecules that modulate novel targets in the innate immune system as next generation therapies for cancer, autoimmunity and inflammatory disorders | Health Technology |
Delinia, Inc.
 Delinia, Inc. BiotechnologyHealth Technology Develops novel therapeutics for the treatment of autoimmune diseases | Health Technology |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Health Technology |
Akero Therapeutics, Inc.
 Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drugs | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Health Technology |
Pheon Therapeutics Ltd.
Pheon Therapeutics Ltd. BiotechnologyHealth Technology Develops antibody drug to treat cancers | Health Technology |
Diagonal Therapeutics, Inc.
Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for oncology, immunology and rare diseases | Health Technology |
